Top-News
Werbung
Attraktive Knock-Outs auf GE HealthCare Technologies Inc
Typ Hebel Bid / Ask WKN
Call
4,5 2,52 € / 2,80 €
SW2UJ1
Typ Hebel Bid / Ask WKN
Put
5,7 0,99 € / 1,10 €
SX2Y8S
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf GE HealthCare Technologies Inc
Gesundheitswesen: Anbieter u. Dienstleister USA

GE HealthCare Technologies Inc Aktie

Aktie
WKN:  A3D3G6 ISIN:  US36266G1076 US-Symbol:  GEHC
60,54 €
-1,49 €
-2,40%
12:52:26 Uhr
Depot/Watchlist
Aktienanzahl *
456,87 Mio.
Marktkapitalisierung *
28,34 Mrd. €
Streubesitz
11,44%
Index-Zugehörigkeit
Nasdaq 100
IR-Website
zur Website
*Stand: 07.01.2025
Weiter abwärts? Short handeln - Jetzt mit Hebel 6,92: VK186G
Werbung

GE HealthCare Technologies Inc News

01.05.25 - ARIVA.DE Redaktion
1,76 Prozent Plus: Nasdaq 100 legt etwas zu (19.915 Pkt.)
Leichte Kurs­gewinne verzeichnen gegenwärtig die Aktien im Nasdaq 100-Index. Das Börsenbarometer steigt deutlich um 1,76 Prozent.
30.04.25 - Businesswire
GE HealthCare reports first quarter 2025 financial results
GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2025.
28.04.25 - Businesswire
GE HealthCare management to present at upcoming investor conferences
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.
24.04.25 - Businesswire
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-​centered breast care during the ...
17.04.25 - Businesswire
GE HealthCare to announce first quarter 2025 results on April 30, 2025
GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management ...
10.04.25 - Businesswire
Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation
Cincinnati Children’s and GE HealthCare (Nasdaq: GEHC) will form a strategic research program focused on driving clinical and technical research to advance innovation for ...
09.04.25 - Businesswire
GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, ...
02.04.25 - PR Newswire
FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices
FDA Watch: The Quiet Gold Rush in AI-​Powered Medical Devices PR Newswire
02.04.25 - PR Newswire
FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices
FDA Watch: The Quiet Gold Rush in AI-​Powered Medical Devices PR Newswire
31.03.25 - Businesswire
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-​Physics Co., Ltd ...
28.03.25 - Businesswire
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
"Revolution Vibe has significantly enhanced our cardiac imaging capabilities, doubling our CCTA capacity while reducing scan times and improving image quality,” shares Dr. ...
27.03.25 - Businesswire
GE HealthCare announces cash dividend for first quarter of 2025
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 ...
27.03.25 - Businesswire
ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session ...
20.03.25 - Businesswire
GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts
GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence ...
18.03.25 - Businesswire
GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions
GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering ...
17.03.25 - Businesswire
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user ...
04.03.25 - Businesswire
GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption
GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-​as-a-service (SaaS) solutions. Four features will be ...
27.02.25 - Businesswire
GE HealthCare names new president and CEO, China
GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective ...
26.02.25 - Businesswire
GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR
GE HealthCare (Nasdaq: GEHC) today unveiled Freelium™, ii a next-​generation sealed magnet platform, that aims to enable high-​quality Magnetic Resonance (MR) imaging with less ...
25.02.25 - Businesswire
Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-​of-its-kind unit dose positron emission tomography myocardial ...

Newssuche

Videos

newspaper
30.04.25 +3,37%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »